nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—CYP2C19—coronary artery disease	0.16	1	CbGaD
Apixaban—ABCG2—Telmisartan—coronary artery disease	0.0193	0.0343	CbGbCtD
Apixaban—ABCG2—Pitavastatin—coronary artery disease	0.0193	0.0343	CbGbCtD
Apixaban—CYP2C8—Fenofibrate—coronary artery disease	0.017	0.0302	CbGbCtD
Apixaban—ABCG2—Ezetimibe—coronary artery disease	0.0143	0.0253	CbGbCtD
Apixaban—ABCG2—Rosuvastatin—coronary artery disease	0.0143	0.0253	CbGbCtD
Apixaban—CYP2C8—Gemfibrozil—coronary artery disease	0.0136	0.0241	CbGbCtD
Apixaban—ABCG2—Pravastatin—coronary artery disease	0.013	0.023	CbGbCtD
Apixaban—ABCB1—Ticagrelor—coronary artery disease	0.0129	0.0229	CbGbCtD
Apixaban—CYP3A5—Clopidogrel—coronary artery disease	0.0123	0.0218	CbGbCtD
Apixaban—CYP2C9—Fenofibrate—coronary artery disease	0.0119	0.021	CbGbCtD
Apixaban—CYP2C8—Clopidogrel—coronary artery disease	0.0118	0.0209	CbGbCtD
Apixaban—CYP2C19—Gemfibrozil—coronary artery disease	0.0114	0.0202	CbGbCtD
Apixaban—CYP3A5—Eplerenone—coronary artery disease	0.0114	0.0202	CbGbCtD
Apixaban—CYP1A2—Gemfibrozil—coronary artery disease	0.0105	0.0187	CbGbCtD
Apixaban—CYP2C8—Pitavastatin—coronary artery disease	0.0103	0.0183	CbGbCtD
Apixaban—CYP2C19—Clopidogrel—coronary artery disease	0.00989	0.0175	CbGbCtD
Apixaban—CYP2C9—Gemfibrozil—coronary artery disease	0.00948	0.0168	CbGbCtD
Apixaban—CYP1A2—Clopidogrel—coronary artery disease	0.00912	0.0162	CbGbCtD
Apixaban—CYP2C19—Telmisartan—coronary artery disease	0.00864	0.0153	CbGbCtD
Apixaban—CYP2C9—Clopidogrel—coronary artery disease	0.00822	0.0146	CbGbCtD
Apixaban—ABCB1—Perindopril—coronary artery disease	0.00798	0.0142	CbGbCtD
Apixaban—ABCB1—Clopidogrel—coronary artery disease	0.00798	0.0142	CbGbCtD
Apixaban—CYP3A5—Rosuvastatin—coronary artery disease	0.0079	0.014	CbGbCtD
Apixaban—CYP3A4—Ticagrelor—coronary artery disease	0.00774	0.0137	CbGbCtD
Apixaban—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.0074	0.0131	CbGbCtD
Apixaban—CYP3A5—Simvastatin—coronary artery disease	0.00734	0.013	CbGbCtD
Apixaban—CYP3A5—Pravastatin—coronary artery disease	0.00719	0.0128	CbGbCtD
Apixaban—CYP3A5—Lovastatin—coronary artery disease	0.00719	0.0128	CbGbCtD
Apixaban—CYP2C9—Pitavastatin—coronary artery disease	0.00719	0.0128	CbGbCtD
Apixaban—CYP2C8—Simvastatin—coronary artery disease	0.00706	0.0125	CbGbCtD
Apixaban—CYP2C9—Valsartan—coronary artery disease	0.00699	0.0124	CbGbCtD
Apixaban—ABCB1—Pitavastatin—coronary artery disease	0.00697	0.0124	CbGbCtD
Apixaban—ABCB1—Telmisartan—coronary artery disease	0.00697	0.0124	CbGbCtD
Apixaban—CYP2C19—Timolol—coronary artery disease	0.00697	0.0124	CbGbCtD
Apixaban—CYP2C8—Pravastatin—coronary artery disease	0.00691	0.0123	CbGbCtD
Apixaban—CYP2C8—Lovastatin—coronary artery disease	0.00691	0.0123	CbGbCtD
Apixaban—CYP3A4—Fenofibrate—coronary artery disease	0.0069	0.0122	CbGbCtD
Apixaban—ABCB1—Enalapril—coronary artery disease	0.00661	0.0117	CbGbCtD
Apixaban—ABCB1—Lisinopril—coronary artery disease	0.00661	0.0117	CbGbCtD
Apixaban—CYP3A5—Atorvastatin—coronary artery disease	0.00655	0.0116	CbGbCtD
Apixaban—CYP2C19—Rosuvastatin—coronary artery disease	0.00637	0.0113	CbGbCtD
Apixaban—CYP2C8—Atorvastatin—coronary artery disease	0.00629	0.0112	CbGbCtD
Apixaban—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00621	0.011	CbGbCtD
Apixaban—CYP3A5—Losartan—coronary artery disease	0.00599	0.0106	CbGbCtD
Apixaban—CYP2C19—Simvastatin—coronary artery disease	0.00592	0.0105	CbGbCtD
Apixaban—CYP2C19—Lovastatin—coronary artery disease	0.0058	0.0103	CbGbCtD
Apixaban—CYP2C8—Losartan—coronary artery disease	0.00576	0.0102	CbGbCtD
Apixaban—ABCB1—Timolol—coronary artery disease	0.00562	0.00998	CbGbCtD
Apixaban—CYP3A4—Gemfibrozil—coronary artery disease	0.00551	0.00978	CbGbCtD
Apixaban—CYP2C9—Rosuvastatin—coronary artery disease	0.0053	0.0094	CbGbCtD
Apixaban—CYP2C19—Atorvastatin—coronary artery disease	0.00528	0.00937	CbGbCtD
Apixaban—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00516	0.00916	CbGbCtD
Apixaban—ABCB1—Ezetimibe—coronary artery disease	0.00514	0.00912	CbGbCtD
Apixaban—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00501	0.00889	CbGbCtD
Apixaban—ABCB1—Captopril—coronary artery disease	0.00495	0.00878	CbGbCtD
Apixaban—CYP2C9—cardial valve—coronary artery disease	0.00494	0.278	CbGeAlD
Apixaban—CYP2C9—Simvastatin—coronary artery disease	0.00493	0.00874	CbGbCtD
Apixaban—CYP2C19—Losartan—coronary artery disease	0.00483	0.00857	CbGbCtD
Apixaban—CYP2C9—Pravastatin—coronary artery disease	0.00482	0.00855	CbGbCtD
Apixaban—CYP2C9—Lovastatin—coronary artery disease	0.00482	0.00855	CbGbCtD
Apixaban—CYP3A4—Clopidogrel—coronary artery disease	0.00478	0.00848	CbGbCtD
Apixaban—ABCB1—Simvastatin—coronary artery disease	0.00478	0.00848	CbGbCtD
Apixaban—ABCB1—Pravastatin—coronary artery disease	0.00468	0.0083	CbGbCtD
Apixaban—ABCB1—Lovastatin—coronary artery disease	0.00468	0.0083	CbGbCtD
Apixaban—CYP1A2—Losartan—coronary artery disease	0.00446	0.00791	CbGbCtD
Apixaban—CYP3A4—Eplerenone—coronary artery disease	0.00444	0.00789	CbGbCtD
Apixaban—CYP2C9—Atorvastatin—coronary artery disease	0.00439	0.00779	CbGbCtD
Apixaban—ABCB1—Atorvastatin—coronary artery disease	0.00426	0.00756	CbGbCtD
Apixaban—CYP2C9—Losartan—coronary artery disease	0.00402	0.00713	CbGbCtD
Apixaban—CYP3A4—Enalapril—coronary artery disease	0.00396	0.00703	CbGbCtD
Apixaban—ABCB1—Losartan—coronary artery disease	0.0039	0.00691	CbGbCtD
Apixaban—CYP3A4—Rosuvastatin—coronary artery disease	0.00308	0.00547	CbGbCtD
Apixaban—CYP3A4—Ezetimibe—coronary artery disease	0.00308	0.00547	CbGbCtD
Apixaban—CYP3A4—Simvastatin—coronary artery disease	0.00286	0.00508	CbGbCtD
Apixaban—CYP3A4—Pravastatin—coronary artery disease	0.0028	0.00497	CbGbCtD
Apixaban—CYP3A4—Lovastatin—coronary artery disease	0.0028	0.00497	CbGbCtD
Apixaban—CYP3A4—Atorvastatin—coronary artery disease	0.00255	0.00453	CbGbCtD
Apixaban—CYP3A4—Losartan—coronary artery disease	0.00233	0.00414	CbGbCtD
Apixaban—CYP2J2—artery—coronary artery disease	0.00214	0.121	CbGeAlD
Apixaban—CYP2J2—cardiac ventricle—coronary artery disease	0.0012	0.0677	CbGeAlD
Apixaban—CYP2J2—myocardium—coronary artery disease	0.00113	0.0636	CbGeAlD
Apixaban—F10—heart—coronary artery disease	0.000961	0.0542	CbGeAlD
Apixaban—F10—cardiovascular system—coronary artery disease	0.000907	0.0511	CbGeAlD
Apixaban—F10—cardiac atrium—coronary artery disease	0.000822	0.0464	CbGeAlD
Apixaban—CYP2J2—heart—coronary artery disease	0.000788	0.0444	CbGeAlD
Apixaban—CYP2J2—cardiovascular system—coronary artery disease	0.000744	0.0419	CbGeAlD
Apixaban—F10—blood—coronary artery disease	0.000717	0.0404	CbGeAlD
Apixaban—CYP2J2—cardiac atrium—coronary artery disease	0.000674	0.038	CbGeAlD
Apixaban—ABCG2—heart—coronary artery disease	0.000299	0.0168	CbGeAlD
Apixaban—CYP2C9—heart—coronary artery disease	0.000273	0.0154	CbGeAlD
Apixaban—CYP2C19—blood—coronary artery disease	0.000263	0.0148	CbGeAlD
Apixaban—CYP2C9—cardiovascular system—coronary artery disease	0.000258	0.0145	CbGeAlD
Apixaban—CYP2C8—blood—coronary artery disease	0.000229	0.0129	CbGeAlD
Apixaban—ABCG2—blood—coronary artery disease	0.000223	0.0126	CbGeAlD
Apixaban—CYP1A2—blood—coronary artery disease	0.000215	0.0121	CbGeAlD
Apixaban—CYP3A5—blood—coronary artery disease	0.000207	0.0117	CbGeAlD
Apixaban—CYP2C9—blood—coronary artery disease	0.000204	0.0115	CbGeAlD
Apixaban—CYP3A4—blood—coronary artery disease	0.000155	0.00875	CbGeAlD
Apixaban—ABCB1—heart—coronary artery disease	0.000147	0.0083	CbGeAlD
Apixaban—ABCB1—cardiovascular system—coronary artery disease	0.000139	0.00784	CbGeAlD
Apixaban—ABCB1—blood—coronary artery disease	0.00011	0.0062	CbGeAlD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Olmesartan—coronary artery disease	0.000103	0.000637	CcSEcCtD
Apixaban—Hepatobiliary disease—Ramipril—coronary artery disease	0.000102	0.000635	CcSEcCtD
Apixaban—Epistaxis—Ramipril—coronary artery disease	0.000102	0.000633	CcSEcCtD
Apixaban—Syncope—Trandolapril—coronary artery disease	0.000102	0.000631	CcSEcCtD
Apixaban—Syncope—Enalapril—coronary artery disease	0.000101	0.000628	CcSEcCtD
Apixaban—Hypotension—Eplerenone—coronary artery disease	0.000101	0.000627	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Niacin—coronary artery disease	0.0001	0.000622	CcSEcCtD
Apixaban—Anaemia—Captopril—coronary artery disease	0.0001	0.000621	CcSEcCtD
Apixaban—Dizziness—Gemfibrozil—coronary artery disease	9.99e-05	0.00062	CcSEcCtD
Apixaban—Syncope—Telmisartan—coronary artery disease	9.98e-05	0.00062	CcSEcCtD
Apixaban—Epistaxis—Timolol—coronary artery disease	9.97e-05	0.000619	CcSEcCtD
Apixaban—Loss of consciousness—Trandolapril—coronary artery disease	9.96e-05	0.000618	CcSEcCtD
Apixaban—Gastrointestinal disorder—Fenofibrate—coronary artery disease	9.95e-05	0.000618	CcSEcCtD
Apixaban—Anaphylactic shock—Valsartan—coronary artery disease	9.94e-05	0.000618	CcSEcCtD
Apixaban—Loss of consciousness—Enalapril—coronary artery disease	9.92e-05	0.000616	CcSEcCtD
Apixaban—Anaphylactic shock—Olmesartan—coronary artery disease	9.9e-05	0.000615	CcSEcCtD
Apixaban—Hypersensitivity—Rosuvastatin—coronary artery disease	9.79e-05	0.000608	CcSEcCtD
Apixaban—Gastrointestinal disorder—Clopidogrel—coronary artery disease	9.78e-05	0.000608	CcSEcCtD
Apixaban—Shock—Valsartan—coronary artery disease	9.78e-05	0.000608	CcSEcCtD
Apixaban—Loss of consciousness—Telmisartan—coronary artery disease	9.78e-05	0.000607	CcSEcCtD
Apixaban—Dizziness—Ticagrelor—coronary artery disease	9.76e-05	0.000606	CcSEcCtD
Apixaban—Nervous system disorder—Valsartan—coronary artery disease	9.75e-05	0.000606	CcSEcCtD
Apixaban—Shock—Olmesartan—coronary artery disease	9.74e-05	0.000605	CcSEcCtD
Apixaban—Thrombocytopenia—Valsartan—coronary artery disease	9.74e-05	0.000605	CcSEcCtD
Apixaban—Anaemia—Perindopril—coronary artery disease	9.71e-05	0.000603	CcSEcCtD
Apixaban—Nervous system disorder—Olmesartan—coronary artery disease	9.71e-05	0.000603	CcSEcCtD
Apixaban—Syncope—Captopril—coronary artery disease	9.7e-05	0.000603	CcSEcCtD
Apixaban—Thrombocytopenia—Olmesartan—coronary artery disease	9.69e-05	0.000602	CcSEcCtD
Apixaban—Anaphylactic shock—Niacin—coronary artery disease	9.67e-05	0.0006	CcSEcCtD
Apixaban—Skin disorder—Valsartan—coronary artery disease	9.66e-05	0.0006	CcSEcCtD
Apixaban—Skin disorder—Olmesartan—coronary artery disease	9.61e-05	0.000597	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Trandolapril—coronary artery disease	9.58e-05	0.000595	CcSEcCtD
Apixaban—Connective tissue disorder—Ramipril—coronary artery disease	9.54e-05	0.000592	CcSEcCtD
Apixaban—Gastrointestinal disorder—Ezetimibe—coronary artery disease	9.53e-05	0.000592	CcSEcCtD
Apixaban—Rash—Gemfibrozil—coronary artery disease	9.53e-05	0.000592	CcSEcCtD
Apixaban—Anaphylactic shock—Pravastatin—coronary artery disease	9.52e-05	0.000591	CcSEcCtD
Apixaban—Dermatitis—Gemfibrozil—coronary artery disease	9.52e-05	0.000591	CcSEcCtD
Apixaban—Shock—Niacin—coronary artery disease	9.51e-05	0.000591	CcSEcCtD
Apixaban—Loss of consciousness—Captopril—coronary artery disease	9.51e-05	0.000591	CcSEcCtD
Apixaban—Hypersensitivity—Acetylsalicylic acid—coronary artery disease	9.51e-05	0.00059	CcSEcCtD
Apixaban—Anaemia—Furosemide—coronary artery disease	9.44e-05	0.000586	CcSEcCtD
Apixaban—Syncope—Perindopril—coronary artery disease	9.42e-05	0.000585	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Telmisartan—coronary artery disease	9.41e-05	0.000584	CcSEcCtD
Apixaban—Skin disorder—Niacin—coronary artery disease	9.39e-05	0.000583	CcSEcCtD
Apixaban—Haematuria—Lisinopril—coronary artery disease	9.35e-05	0.000581	CcSEcCtD
Apixaban—Gastrointestinal disorder—Eplerenone—coronary artery disease	9.33e-05	0.000579	CcSEcCtD
Apixaban—Connective tissue disorder—Timolol—coronary artery disease	9.32e-05	0.000579	CcSEcCtD
Apixaban—Thrombocytopenia—Pravastatin—coronary artery disease	9.32e-05	0.000579	CcSEcCtD
Apixaban—Rash—Ticagrelor—coronary artery disease	9.3e-05	0.000578	CcSEcCtD
Apixaban—Dermatitis—Ticagrelor—coronary artery disease	9.3e-05	0.000577	CcSEcCtD
Apixaban—Hypotension—Valsartan—coronary artery disease	9.29e-05	0.000577	CcSEcCtD
Apixaban—Hepatobiliary disease—Lisinopril—coronary artery disease	9.27e-05	0.000576	CcSEcCtD
Apixaban—Epistaxis—Lisinopril—coronary artery disease	9.25e-05	0.000574	CcSEcCtD
Apixaban—Hypotension—Olmesartan—coronary artery disease	9.25e-05	0.000574	CcSEcCtD
Apixaban—Loss of consciousness—Perindopril—coronary artery disease	9.23e-05	0.000573	CcSEcCtD
Apixaban—Anaphylactic shock—Enalapril—coronary artery disease	9.21e-05	0.000572	CcSEcCtD
Apixaban—Anaemia—Losartan—coronary artery disease	9.11e-05	0.000566	CcSEcCtD
Apixaban—Shock—Trandolapril—coronary artery disease	9.1e-05	0.000565	CcSEcCtD
Apixaban—Gastrointestinal disorder—Simvastatin—coronary artery disease	9.09e-05	0.000565	CcSEcCtD
Apixaban—Anaphylactic shock—Telmisartan—coronary artery disease	9.08e-05	0.000564	CcSEcCtD
Apixaban—Nervous system disorder—Trandolapril—coronary artery disease	9.07e-05	0.000563	CcSEcCtD
Apixaban—Shock—Enalapril—coronary artery disease	9.06e-05	0.000563	CcSEcCtD
Apixaban—Thrombocytopenia—Trandolapril—coronary artery disease	9.05e-05	0.000562	CcSEcCtD
Apixaban—Hypotension—Niacin—coronary artery disease	9.03e-05	0.000561	CcSEcCtD
Apixaban—Thrombocytopenia—Enalapril—coronary artery disease	9.02e-05	0.00056	CcSEcCtD
Apixaban—Skin disorder—Trandolapril—coronary artery disease	8.98e-05	0.000558	CcSEcCtD
Apixaban—Nausea—Gemfibrozil—coronary artery disease	8.97e-05	0.000557	CcSEcCtD
Apixaban—Shock—Telmisartan—coronary artery disease	8.94e-05	0.000555	CcSEcCtD
Apixaban—Nervous system disorder—Telmisartan—coronary artery disease	8.91e-05	0.000553	CcSEcCtD
Apixaban—Thrombocytopenia—Telmisartan—coronary artery disease	8.89e-05	0.000552	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Perindopril—coronary artery disease	8.88e-05	0.000552	CcSEcCtD
Apixaban—Eye disorder—Timolol—coronary artery disease	8.87e-05	0.000551	CcSEcCtD
Apixaban—Syncope—Losartan—coronary artery disease	8.84e-05	0.000549	CcSEcCtD
Apixaban—Anaphylactic shock—Captopril—coronary artery disease	8.83e-05	0.000548	CcSEcCtD
Apixaban—Skin disorder—Telmisartan—coronary artery disease	8.82e-05	0.000548	CcSEcCtD
Apixaban—Dizziness—Rosuvastatin—coronary artery disease	8.78e-05	0.000546	CcSEcCtD
Apixaban—Immune system disorder—Ramipril—coronary artery disease	8.77e-05	0.000544	CcSEcCtD
Apixaban—Nausea—Ticagrelor—coronary artery disease	8.77e-05	0.000544	CcSEcCtD
Apixaban—Mediastinal disorder—Ramipril—coronary artery disease	8.75e-05	0.000543	CcSEcCtD
Apixaban—Urinary tract disorder—Lisinopril—coronary artery disease	8.69e-05	0.00054	CcSEcCtD
Apixaban—Shock—Captopril—coronary artery disease	8.69e-05	0.00054	CcSEcCtD
Apixaban—Loss of consciousness—Losartan—coronary artery disease	8.66e-05	0.000538	CcSEcCtD
Apixaban—Thrombocytopenia—Captopril—coronary artery disease	8.65e-05	0.000537	CcSEcCtD
Apixaban—Hypotension—Trandolapril—coronary artery disease	8.64e-05	0.000536	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Furosemide—coronary artery disease	8.64e-05	0.000536	CcSEcCtD
Apixaban—Urethral disorder—Lisinopril—coronary artery disease	8.63e-05	0.000536	CcSEcCtD
Apixaban—Angiopathy—Timolol—coronary artery disease	8.61e-05	0.000535	CcSEcCtD
Apixaban—Hypotension—Enalapril—coronary artery disease	8.6e-05	0.000534	CcSEcCtD
Apixaban—Gastrointestinal disorder—Valsartan—coronary artery disease	8.59e-05	0.000533	CcSEcCtD
Apixaban—Anaphylactic shock—Perindopril—coronary artery disease	8.57e-05	0.000533	CcSEcCtD
Apixaban—Immune system disorder—Timolol—coronary artery disease	8.57e-05	0.000532	CcSEcCtD
Apixaban—Mediastinal disorder—Timolol—coronary artery disease	8.55e-05	0.000531	CcSEcCtD
Apixaban—Gastrointestinal disorder—Olmesartan—coronary artery disease	8.54e-05	0.000531	CcSEcCtD
Apixaban—Dizziness—Acetylsalicylic acid—coronary artery disease	8.53e-05	0.00053	CcSEcCtD
Apixaban—Hypersensitivity—Fenofibrate—coronary artery disease	8.49e-05	0.000528	CcSEcCtD
Apixaban—Hypotension—Telmisartan—coronary artery disease	8.49e-05	0.000527	CcSEcCtD
Apixaban—Shock—Perindopril—coronary artery disease	8.44e-05	0.000524	CcSEcCtD
Apixaban—Nervous system disorder—Perindopril—coronary artery disease	8.41e-05	0.000522	CcSEcCtD
Apixaban—Thrombocytopenia—Perindopril—coronary artery disease	8.4e-05	0.000521	CcSEcCtD
Apixaban—Rash—Rosuvastatin—coronary artery disease	8.38e-05	0.00052	CcSEcCtD
Apixaban—Dermatitis—Rosuvastatin—coronary artery disease	8.37e-05	0.00052	CcSEcCtD
Apixaban—Hypersensitivity—Clopidogrel—coronary artery disease	8.35e-05	0.000519	CcSEcCtD
Apixaban—Gastrointestinal disorder—Niacin—coronary artery disease	8.35e-05	0.000518	CcSEcCtD
Apixaban—Anaphylactic shock—Furosemide—coronary artery disease	8.34e-05	0.000518	CcSEcCtD
Apixaban—Skin disorder—Perindopril—coronary artery disease	8.33e-05	0.000517	CcSEcCtD
Apixaban—Hypersensitivity—Lovastatin—coronary artery disease	8.29e-05	0.000515	CcSEcCtD
Apixaban—Hypotension—Captopril—coronary artery disease	8.25e-05	0.000512	CcSEcCtD
Apixaban—Shock—Furosemide—coronary artery disease	8.2e-05	0.000509	CcSEcCtD
Apixaban—Nervous system disorder—Furosemide—coronary artery disease	8.17e-05	0.000508	CcSEcCtD
Apixaban—Thrombocytopenia—Furosemide—coronary artery disease	8.16e-05	0.000507	CcSEcCtD
Apixaban—Rash—Acetylsalicylic acid—coronary artery disease	8.14e-05	0.000505	CcSEcCtD
Apixaban—Hypersensitivity—Ezetimibe—coronary artery disease	8.14e-05	0.000505	CcSEcCtD
Apixaban—Dermatitis—Acetylsalicylic acid—coronary artery disease	8.13e-05	0.000505	CcSEcCtD
Apixaban—Skin disorder—Furosemide—coronary artery disease	8.1e-05	0.000503	CcSEcCtD
Apixaban—Anaphylactic shock—Losartan—coronary artery disease	8.04e-05	0.000499	CcSEcCtD
Apixaban—Hypotension—Perindopril—coronary artery disease	8.01e-05	0.000498	CcSEcCtD
Apixaban—Angiopathy—Lisinopril—coronary artery disease	7.99e-05	0.000496	CcSEcCtD
Apixaban—Gastrointestinal disorder—Trandolapril—coronary artery disease	7.98e-05	0.000496	CcSEcCtD
Apixaban—Mediastinal disorder—Lisinopril—coronary artery disease	7.93e-05	0.000493	CcSEcCtD
Apixaban—Shock—Losartan—coronary artery disease	7.91e-05	0.000491	CcSEcCtD
Apixaban—Nausea—Rosuvastatin—coronary artery disease	7.89e-05	0.00049	CcSEcCtD
Apixaban—Nervous system disorder—Losartan—coronary artery disease	7.89e-05	0.00049	CcSEcCtD
Apixaban—Thrombocytopenia—Losartan—coronary artery disease	7.87e-05	0.000489	CcSEcCtD
Apixaban—Gastrointestinal disorder—Telmisartan—coronary artery disease	7.84e-05	0.000487	CcSEcCtD
Apixaban—Hypotension—Furosemide—coronary artery disease	7.79e-05	0.000484	CcSEcCtD
Apixaban—Hypersensitivity—Simvastatin—coronary artery disease	7.76e-05	0.000482	CcSEcCtD
Apixaban—Nausea—Acetylsalicylic acid—coronary artery disease	7.67e-05	0.000476	CcSEcCtD
Apixaban—Dizziness—Fenofibrate—coronary artery disease	7.62e-05	0.000473	CcSEcCtD
Apixaban—Syncope—Ramipril—coronary artery disease	7.58e-05	0.000471	CcSEcCtD
Apixaban—Hypotension—Losartan—coronary artery disease	7.52e-05	0.000467	CcSEcCtD
Apixaban—Dizziness—Clopidogrel—coronary artery disease	7.49e-05	0.000465	CcSEcCtD
Apixaban—Dizziness—Lovastatin—coronary artery disease	7.44e-05	0.000462	CcSEcCtD
Apixaban—Loss of consciousness—Ramipril—coronary artery disease	7.43e-05	0.000461	CcSEcCtD
Apixaban—Syncope—Timolol—coronary artery disease	7.41e-05	0.00046	CcSEcCtD
Apixaban—Gastrointestinal disorder—Perindopril—coronary artery disease	7.4e-05	0.00046	CcSEcCtD
Apixaban—Hypersensitivity—Valsartan—coronary artery disease	7.33e-05	0.000455	CcSEcCtD
Apixaban—Dizziness—Ezetimibe—coronary artery disease	7.3e-05	0.000453	CcSEcCtD
Apixaban—Rash—Fenofibrate—coronary artery disease	7.27e-05	0.000451	CcSEcCtD
Apixaban—Dermatitis—Fenofibrate—coronary artery disease	7.26e-05	0.000451	CcSEcCtD
Apixaban—Loss of consciousness—Timolol—coronary artery disease	7.26e-05	0.000451	CcSEcCtD
Apixaban—Gastrointestinal disorder—Furosemide—coronary artery disease	7.2e-05	0.000447	CcSEcCtD
Apixaban—Dizziness—Eplerenone—coronary artery disease	7.15e-05	0.000444	CcSEcCtD
Apixaban—Rash—Clopidogrel—coronary artery disease	7.15e-05	0.000444	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	7.14e-05	0.000444	CcSEcCtD
Apixaban—Dermatitis—Clopidogrel—coronary artery disease	7.14e-05	0.000443	CcSEcCtD
Apixaban—Hypersensitivity—Niacin—coronary artery disease	7.12e-05	0.000442	CcSEcCtD
Apixaban—Rash—Lovastatin—coronary artery disease	7.1e-05	0.000441	CcSEcCtD
Apixaban—Dermatitis—Lovastatin—coronary artery disease	7.09e-05	0.00044	CcSEcCtD
Apixaban—Anaemia—Lisinopril—coronary artery disease	7.08e-05	0.00044	CcSEcCtD
Apixaban—Hypersensitivity—Pravastatin—coronary artery disease	7.01e-05	0.000436	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	6.98e-05	0.000434	CcSEcCtD
Apixaban—Dizziness—Simvastatin—coronary artery disease	6.96e-05	0.000432	CcSEcCtD
Apixaban—Rash—Ezetimibe—coronary artery disease	6.96e-05	0.000432	CcSEcCtD
Apixaban—Dermatitis—Ezetimibe—coronary artery disease	6.96e-05	0.000432	CcSEcCtD
Apixaban—Anaphylactic shock—Ramipril—coronary artery disease	6.9e-05	0.000428	CcSEcCtD
Apixaban—Syncope—Lisinopril—coronary artery disease	6.87e-05	0.000427	CcSEcCtD
Apixaban—Nausea—Fenofibrate—coronary artery disease	6.85e-05	0.000425	CcSEcCtD
Apixaban—Rash—Eplerenone—coronary artery disease	6.81e-05	0.000423	CcSEcCtD
Apixaban—Hypersensitivity—Trandolapril—coronary artery disease	6.81e-05	0.000423	CcSEcCtD
Apixaban—Dermatitis—Eplerenone—coronary artery disease	6.81e-05	0.000423	CcSEcCtD
Apixaban—Shock—Ramipril—coronary artery disease	6.78e-05	0.000421	CcSEcCtD
Apixaban—Hypersensitivity—Enalapril—coronary artery disease	6.78e-05	0.000421	CcSEcCtD
Apixaban—Nervous system disorder—Ramipril—coronary artery disease	6.76e-05	0.00042	CcSEcCtD
Apixaban—Thrombocytopenia—Ramipril—coronary artery disease	6.75e-05	0.000419	CcSEcCtD
Apixaban—Anaphylactic shock—Timolol—coronary artery disease	6.74e-05	0.000419	CcSEcCtD
Apixaban—Loss of consciousness—Lisinopril—coronary artery disease	6.74e-05	0.000418	CcSEcCtD
Apixaban—Nausea—Clopidogrel—coronary artery disease	6.73e-05	0.000418	CcSEcCtD
Apixaban—Skin disorder—Ramipril—coronary artery disease	6.7e-05	0.000416	CcSEcCtD
Apixaban—Hypersensitivity—Telmisartan—coronary artery disease	6.69e-05	0.000416	CcSEcCtD
Apixaban—Nausea—Lovastatin—coronary artery disease	6.69e-05	0.000415	CcSEcCtD
Apixaban—Rash—Simvastatin—coronary artery disease	6.64e-05	0.000412	CcSEcCtD
Apixaban—Dermatitis—Simvastatin—coronary artery disease	6.63e-05	0.000412	CcSEcCtD
Apixaban—Shock—Timolol—coronary artery disease	6.63e-05	0.000412	CcSEcCtD
Apixaban—Nervous system disorder—Timolol—coronary artery disease	6.61e-05	0.000411	CcSEcCtD
Apixaban—Dizziness—Valsartan—coronary artery disease	6.58e-05	0.000408	CcSEcCtD
Apixaban—Nausea—Ezetimibe—coronary artery disease	6.56e-05	0.000407	CcSEcCtD
Apixaban—Skin disorder—Timolol—coronary artery disease	6.55e-05	0.000407	CcSEcCtD
Apixaban—Dizziness—Olmesartan—coronary artery disease	6.54e-05	0.000406	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	6.48e-05	0.000402	CcSEcCtD
Apixaban—Hypotension—Ramipril—coronary artery disease	6.44e-05	0.0004	CcSEcCtD
Apixaban—Nausea—Eplerenone—coronary artery disease	6.42e-05	0.000399	CcSEcCtD
Apixaban—Dizziness—Niacin—coronary artery disease	6.39e-05	0.000397	CcSEcCtD
Apixaban—Hypotension—Timolol—coronary artery disease	6.3e-05	0.000391	CcSEcCtD
Apixaban—Dizziness—Pravastatin—coronary artery disease	6.3e-05	0.000391	CcSEcCtD
Apixaban—Rash—Valsartan—coronary artery disease	6.27e-05	0.000389	CcSEcCtD
Apixaban—Dermatitis—Valsartan—coronary artery disease	6.26e-05	0.000389	CcSEcCtD
Apixaban—Nausea—Simvastatin—coronary artery disease	6.25e-05	0.000388	CcSEcCtD
Apixaban—Anaphylactic shock—Lisinopril—coronary artery disease	6.25e-05	0.000388	CcSEcCtD
Apixaban—Rash—Olmesartan—coronary artery disease	6.24e-05	0.000388	CcSEcCtD
Apixaban—Dermatitis—Olmesartan—coronary artery disease	6.23e-05	0.000387	CcSEcCtD
Apixaban—Shock—Lisinopril—coronary artery disease	6.15e-05	0.000382	CcSEcCtD
Apixaban—Hypersensitivity—Furosemide—coronary artery disease	6.14e-05	0.000381	CcSEcCtD
Apixaban—Thrombocytopenia—Lisinopril—coronary artery disease	6.12e-05	0.00038	CcSEcCtD
Apixaban—Dizziness—Trandolapril—coronary artery disease	6.11e-05	0.00038	CcSEcCtD
Apixaban—Rash—Niacin—coronary artery disease	6.1e-05	0.000379	CcSEcCtD
Apixaban—Dermatitis—Niacin—coronary artery disease	6.09e-05	0.000378	CcSEcCtD
Apixaban—Dizziness—Enalapril—coronary artery disease	6.09e-05	0.000378	CcSEcCtD
Apixaban—Skin disorder—Lisinopril—coronary artery disease	6.07e-05	0.000377	CcSEcCtD
Apixaban—Dizziness—Telmisartan—coronary artery disease	6.01e-05	0.000373	CcSEcCtD
Apixaban—Rash—Pravastatin—coronary artery disease	6e-05	0.000373	CcSEcCtD
Apixaban—Dermatitis—Pravastatin—coronary artery disease	6e-05	0.000372	CcSEcCtD
Apixaban—Gastrointestinal disorder—Ramipril—coronary artery disease	5.95e-05	0.00037	CcSEcCtD
Apixaban—Hypersensitivity—Losartan—coronary artery disease	5.93e-05	0.000368	CcSEcCtD
Apixaban—Nausea—Valsartan—coronary artery disease	5.91e-05	0.000367	CcSEcCtD
Apixaban—Nausea—Olmesartan—coronary artery disease	5.88e-05	0.000365	CcSEcCtD
Apixaban—Hypotension—Lisinopril—coronary artery disease	5.84e-05	0.000363	CcSEcCtD
Apixaban—Dizziness—Captopril—coronary artery disease	5.84e-05	0.000363	CcSEcCtD
Apixaban—Rash—Trandolapril—coronary artery disease	5.83e-05	0.000362	CcSEcCtD
Apixaban—Dermatitis—Trandolapril—coronary artery disease	5.82e-05	0.000362	CcSEcCtD
Apixaban—Gastrointestinal disorder—Timolol—coronary artery disease	5.82e-05	0.000361	CcSEcCtD
Apixaban—Rash—Enalapril—coronary artery disease	5.81e-05	0.000361	CcSEcCtD
Apixaban—Dermatitis—Enalapril—coronary artery disease	5.8e-05	0.00036	CcSEcCtD
Apixaban—Nausea—Niacin—coronary artery disease	5.74e-05	0.000357	CcSEcCtD
Apixaban—Rash—Telmisartan—coronary artery disease	5.73e-05	0.000356	CcSEcCtD
Apixaban—Dermatitis—Telmisartan—coronary artery disease	5.72e-05	0.000355	CcSEcCtD
Apixaban—Dizziness—Perindopril—coronary artery disease	5.67e-05	0.000352	CcSEcCtD
Apixaban—Nausea—Pravastatin—coronary artery disease	5.65e-05	0.000351	CcSEcCtD
Apixaban—Rash—Captopril—coronary artery disease	5.57e-05	0.000346	CcSEcCtD
Apixaban—Dermatitis—Captopril—coronary artery disease	5.56e-05	0.000345	CcSEcCtD
Apixaban—Dizziness—Furosemide—coronary artery disease	5.51e-05	0.000342	CcSEcCtD
Apixaban—Nausea—Trandolapril—coronary artery disease	5.49e-05	0.000341	CcSEcCtD
Apixaban—Nausea—Enalapril—coronary artery disease	5.47e-05	0.00034	CcSEcCtD
Apixaban—Rash—Perindopril—coronary artery disease	5.41e-05	0.000336	CcSEcCtD
Apixaban—Dermatitis—Perindopril—coronary artery disease	5.4e-05	0.000335	CcSEcCtD
Apixaban—Gastrointestinal disorder—Lisinopril—coronary artery disease	5.4e-05	0.000335	CcSEcCtD
Apixaban—Nausea—Telmisartan—coronary artery disease	5.39e-05	0.000335	CcSEcCtD
Apixaban—Dizziness—Losartan—coronary artery disease	5.32e-05	0.00033	CcSEcCtD
Apixaban—Rash—Furosemide—coronary artery disease	5.26e-05	0.000326	CcSEcCtD
Apixaban—Dermatitis—Furosemide—coronary artery disease	5.25e-05	0.000326	CcSEcCtD
Apixaban—Nausea—Captopril—coronary artery disease	5.25e-05	0.000326	CcSEcCtD
Apixaban—Nausea—Perindopril—coronary artery disease	5.09e-05	0.000316	CcSEcCtD
Apixaban—Hypersensitivity—Ramipril—coronary artery disease	5.08e-05	0.000316	CcSEcCtD
Apixaban—Rash—Losartan—coronary artery disease	5.07e-05	0.000315	CcSEcCtD
Apixaban—Dermatitis—Losartan—coronary artery disease	5.07e-05	0.000315	CcSEcCtD
Apixaban—Hypersensitivity—Timolol—coronary artery disease	4.97e-05	0.000308	CcSEcCtD
Apixaban—Nausea—Furosemide—coronary artery disease	4.95e-05	0.000307	CcSEcCtD
Apixaban—Nausea—Losartan—coronary artery disease	4.78e-05	0.000297	CcSEcCtD
Apixaban—Hypersensitivity—Lisinopril—coronary artery disease	4.61e-05	0.000286	CcSEcCtD
Apixaban—Dizziness—Ramipril—coronary artery disease	4.56e-05	0.000283	CcSEcCtD
Apixaban—Dizziness—Timolol—coronary artery disease	4.46e-05	0.000277	CcSEcCtD
Apixaban—Rash—Ramipril—coronary artery disease	4.35e-05	0.00027	CcSEcCtD
Apixaban—Dermatitis—Ramipril—coronary artery disease	4.34e-05	0.00027	CcSEcCtD
Apixaban—Rash—Timolol—coronary artery disease	4.25e-05	0.000264	CcSEcCtD
Apixaban—Dermatitis—Timolol—coronary artery disease	4.25e-05	0.000264	CcSEcCtD
Apixaban—Dizziness—Lisinopril—coronary artery disease	4.14e-05	0.000257	CcSEcCtD
Apixaban—Nausea—Ramipril—coronary artery disease	4.1e-05	0.000254	CcSEcCtD
Apixaban—Nausea—Timolol—coronary artery disease	4e-05	0.000249	CcSEcCtD
Apixaban—Rash—Lisinopril—coronary artery disease	3.94e-05	0.000245	CcSEcCtD
Apixaban—Dermatitis—Lisinopril—coronary artery disease	3.94e-05	0.000245	CcSEcCtD
Apixaban—Nausea—Lisinopril—coronary artery disease	3.71e-05	0.000231	CcSEcCtD
Apixaban—CYP1A2—Metabolism—VCAN—coronary artery disease	3.19e-06	3.26e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—HMGCR—coronary artery disease	3.19e-06	3.25e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GOT2—coronary artery disease	3.19e-06	3.25e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CAT—coronary artery disease	3.19e-06	3.25e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SLC22A3—coronary artery disease	3.18e-06	3.24e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALDOA—coronary artery disease	3.17e-06	3.23e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GOT1—coronary artery disease	3.16e-06	3.22e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GGT1—coronary artery disease	3.16e-06	3.22e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ARNTL—coronary artery disease	3.13e-06	3.2e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HADH—coronary artery disease	3.13e-06	3.2e-05	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	3.13e-06	3.19e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—APOB—coronary artery disease	3.09e-06	3.16e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—DCN—coronary artery disease	3.08e-06	3.14e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PSMB5—coronary artery disease	3.08e-06	3.14e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PSMA6—coronary artery disease	3.08e-06	3.14e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.07e-06	3.13e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PPARG—coronary artery disease	3.01e-06	3.07e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GSTM1—coronary artery disease	3.01e-06	3.07e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CTGF—coronary artery disease	3.01e-06	3.07e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PLCB1—coronary artery disease	3e-06	3.07e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALDH2—coronary artery disease	2.99e-06	3.05e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GOT2—coronary artery disease	2.98e-06	3.04e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—HMGCR—coronary artery disease	2.98e-06	3.04e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—APOA2—coronary artery disease	2.97e-06	3.03e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	2.97e-06	3.03e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GPX2—coronary artery disease	2.97e-06	3.03e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—POMC—coronary artery disease	2.97e-06	3.03e-05	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—AKT1—coronary artery disease	2.96e-06	3.02e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—LPL—coronary artery disease	2.95e-06	3.02e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.95e-06	3.01e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ABCG5—coronary artery disease	2.93e-06	2.99e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HK1—coronary artery disease	2.93e-06	2.99e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SULT1A1—coronary artery disease	2.93e-06	2.99e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GPX4—coronary artery disease	2.93e-06	2.99e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PLCB1—coronary artery disease	2.93e-06	2.99e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	2.92e-06	2.98e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—HBA1—coronary artery disease	2.92e-06	2.98e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—LIPC—coronary artery disease	2.92e-06	2.98e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP2C19—coronary artery disease	2.92e-06	2.98e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	2.92e-06	2.98e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ABCA1—coronary artery disease	2.91e-06	2.97e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HADHA—coronary artery disease	2.9e-06	2.96e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—APOC3—coronary artery disease	2.9e-06	2.96e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GPX1—coronary artery disease	2.88e-06	2.94e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—LDLR—coronary artery disease	2.88e-06	2.94e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	2.88e-06	2.94e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTA1—coronary artery disease	2.87e-06	2.92e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SLC9A1—coronary artery disease	2.85e-06	2.91e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTT1—coronary artery disease	2.85e-06	2.91e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ABCA1—coronary artery disease	2.84e-06	2.9e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSTP1—coronary artery disease	2.84e-06	2.9e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—LPA—coronary artery disease	2.83e-06	2.89e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GGT1—coronary artery disease	2.82e-06	2.88e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GOT1—coronary artery disease	2.82e-06	2.88e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GCLC—coronary artery disease	2.81e-06	2.87e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CETP—coronary artery disease	2.81e-06	2.87e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	2.81e-06	2.87e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CD36—coronary artery disease	2.81e-06	2.87e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—HMOX1—coronary artery disease	2.8e-06	2.86e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SDC1—coronary artery disease	2.78e-06	2.84e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PPP2CA—coronary artery disease	2.77e-06	2.83e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CAT—coronary artery disease	2.76e-06	2.82e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GGT1—coronary artery disease	2.75e-06	2.81e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GOT1—coronary artery disease	2.75e-06	2.81e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PLCB3—coronary artery disease	2.74e-06	2.8e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PLCB1—coronary artery disease	2.74e-06	2.8e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—APOA5—coronary artery disease	2.72e-06	2.77e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ALB—coronary artery disease	2.71e-06	2.76e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.69e-06	2.74e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—APOB—coronary artery disease	2.68e-06	2.74e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—P4HB—coronary artery disease	2.66e-06	2.72e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—MTHFR—coronary artery disease	2.66e-06	2.72e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ABCA1—coronary artery disease	2.65e-06	2.71e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PSMA6—coronary artery disease	2.63e-06	2.68e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PSMB5—coronary artery disease	2.63e-06	2.68e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	2.62e-06	2.68e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	2.62e-06	2.67e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSTM1—coronary artery disease	2.61e-06	2.66e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—NOS3—coronary artery disease	2.59e-06	2.64e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GGT1—coronary artery disease	2.57e-06	2.62e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GOT1—coronary artery disease	2.57e-06	2.62e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CTGF—coronary artery disease	2.57e-06	2.62e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—LPL—coronary artery disease	2.56e-06	2.61e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—HMGCR—coronary artery disease	2.55e-06	2.6e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GOT2—coronary artery disease	2.55e-06	2.6e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTP1—coronary artery disease	2.53e-06	2.58e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—AGT—coronary artery disease	2.53e-06	2.58e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	2.51e-06	2.56e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—HMOX1—coronary artery disease	2.5e-06	2.55e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GPX1—coronary artery disease	2.5e-06	2.55e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—APOE—coronary artery disease	2.48e-06	2.53e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTP1—coronary artery disease	2.47e-06	2.52e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—VCAN—coronary artery disease	2.47e-06	2.52e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CAT—coronary artery disease	2.46e-06	2.52e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PPARGC1A—coronary artery disease	2.45e-06	2.5e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—APOA1—coronary artery disease	2.45e-06	2.5e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.45e-06	2.5e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—HMOX1—coronary artery disease	2.44e-06	2.49e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CD36—coronary artery disease	2.43e-06	2.48e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CAT—coronary artery disease	2.41e-06	2.45e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PPP2CA—coronary artery disease	2.4e-06	2.45e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—APOB—coronary artery disease	2.39e-06	2.44e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—DCN—coronary artery disease	2.37e-06	2.42e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PTGS2—coronary artery disease	2.37e-06	2.42e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PLCB1—coronary artery disease	2.34e-06	2.39e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—APOB—coronary artery disease	2.34e-06	2.38e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTM1—coronary artery disease	2.33e-06	2.38e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.31e-06	2.36e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTP1—coronary artery disease	2.31e-06	2.36e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—MTHFR—coronary artery disease	2.3e-06	2.35e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.3e-06	2.34e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	2.29e-06	2.34e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—LPL—coronary artery disease	2.28e-06	2.33e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—HMOX1—coronary artery disease	2.28e-06	2.32e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTM1—coronary artery disease	2.27e-06	2.32e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ABCA1—coronary artery disease	2.27e-06	2.32e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—LIPC—coronary artery disease	2.25e-06	2.3e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HBA1—coronary artery disease	2.25e-06	2.3e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.25e-06	2.3e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.25e-06	2.3e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CAT—coronary artery disease	2.25e-06	2.29e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—APOC3—coronary artery disease	2.24e-06	2.28e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—LPL—coronary artery disease	2.23e-06	2.28e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GPX1—coronary artery disease	2.23e-06	2.27e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—LDLR—coronary artery disease	2.22e-06	2.27e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.2e-06	2.24e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.2e-06	2.24e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GGT1—coronary artery disease	2.2e-06	2.24e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GOT1—coronary artery disease	2.2e-06	2.24e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—AGT—coronary artery disease	2.19e-06	2.23e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—APOB—coronary artery disease	2.18e-06	2.23e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GPX1—coronary artery disease	2.18e-06	2.22e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GCLC—coronary artery disease	2.17e-06	2.22e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CETP—coronary artery disease	2.17e-06	2.22e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CD36—coronary artery disease	2.17e-06	2.22e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PPARG—coronary artery disease	2.16e-06	2.2e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SDC1—coronary artery disease	2.15e-06	2.19e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—APOE—coronary artery disease	2.15e-06	2.19e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PPP2CA—coronary artery disease	2.14e-06	2.19e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—POMC—coronary artery disease	2.13e-06	2.17e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTM1—coronary artery disease	2.12e-06	2.17e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—APOA1—coronary artery disease	2.12e-06	2.16e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CD36—coronary artery disease	2.12e-06	2.16e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PPP2CA—coronary artery disease	2.09e-06	2.14e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—LPL—coronary artery disease	2.08e-06	2.13e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—MTHFR—coronary artery disease	2.06e-06	2.1e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GPX1—coronary artery disease	2.03e-06	2.07e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.03e-06	2.07e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.03e-06	2.07e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.03e-06	2.07e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—MTHFR—coronary artery disease	2.01e-06	2.05e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CTGF—coronary artery disease	1.98e-06	2.02e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CD36—coronary artery disease	1.98e-06	2.02e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTP1—coronary artery disease	1.97e-06	2.01e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.96e-06	2e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GOT2—coronary artery disease	1.96e-06	2e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	1.96e-06	2e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PPP2CA—coronary artery disease	1.95e-06	1.99e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—AGT—coronary artery disease	1.95e-06	1.99e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—HMOX1—coronary artery disease	1.95e-06	1.99e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ALB—coronary artery disease	1.94e-06	1.98e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CAT—coronary artery disease	1.92e-06	1.96e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—APOE—coronary artery disease	1.91e-06	1.95e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—AGT—coronary artery disease	1.91e-06	1.95e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—APOA1—coronary artery disease	1.89e-06	1.93e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—MTHFR—coronary artery disease	1.88e-06	1.91e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—APOE—coronary artery disease	1.87e-06	1.91e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PPARG—coronary artery disease	1.87e-06	1.91e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—APOB—coronary artery disease	1.86e-06	1.9e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—NOS3—coronary artery disease	1.86e-06	1.89e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—APOA1—coronary artery disease	1.85e-06	1.89e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—POMC—coronary artery disease	1.84e-06	1.88e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTM1—coronary artery disease	1.81e-06	1.85e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.81e-06	1.85e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.81e-06	1.84e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—AGT—coronary artery disease	1.78e-06	1.82e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—LPL—coronary artery disease	1.78e-06	1.82e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.75e-06	1.79e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—APOE—coronary artery disease	1.75e-06	1.78e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GPX1—coronary artery disease	1.74e-06	1.77e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—APOA1—coronary artery disease	1.73e-06	1.76e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PTGS2—coronary artery disease	1.7e-06	1.73e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GGT1—coronary artery disease	1.7e-06	1.73e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GOT1—coronary artery disease	1.7e-06	1.73e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CD36—coronary artery disease	1.69e-06	1.73e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ALB—coronary artery disease	1.68e-06	1.71e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PPP2CA—coronary artery disease	1.67e-06	1.7e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PPARG—coronary artery disease	1.67e-06	1.7e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.65e-06	1.69e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—POMC—coronary artery disease	1.64e-06	1.68e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PPARG—coronary artery disease	1.63e-06	1.66e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—NOS3—coronary artery disease	1.61e-06	1.64e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—POMC—coronary artery disease	1.61e-06	1.64e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—MTHFR—coronary artery disease	1.6e-06	1.64e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.52e-06	1.55e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—AGT—coronary artery disease	1.52e-06	1.55e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PPARG—coronary artery disease	1.52e-06	1.55e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.51e-06	1.54e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.5e-06	1.53e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—POMC—coronary artery disease	1.5e-06	1.53e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ALB—coronary artery disease	1.5e-06	1.53e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—APOE—coronary artery disease	1.49e-06	1.52e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CAT—coronary artery disease	1.48e-06	1.51e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—APOA1—coronary artery disease	1.47e-06	1.51e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PTGS2—coronary artery disease	1.47e-06	1.5e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ALB—coronary artery disease	1.46e-06	1.49e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CA—coronary artery disease	1.46e-06	1.49e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—APOB—coronary artery disease	1.44e-06	1.47e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—NOS3—coronary artery disease	1.43e-06	1.46e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.41e-06	1.44e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—NOS3—coronary artery disease	1.4e-06	1.43e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.4e-06	1.43e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—LPL—coronary artery disease	1.37e-06	1.4e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ALB—coronary artery disease	1.37e-06	1.4e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GPX1—coronary artery disease	1.34e-06	1.37e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PTGS2—coronary artery disease	1.31e-06	1.34e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NOS3—coronary artery disease	1.31e-06	1.34e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CD36—coronary artery disease	1.31e-06	1.33e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PPARG—coronary artery disease	1.3e-06	1.33e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.29e-06	1.32e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—POMC—coronary artery disease	1.28e-06	1.31e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PTGS2—coronary artery disease	1.28e-06	1.31e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.24e-06	1.26e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.2e-06	1.22e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—AKT1—coronary artery disease	1.19e-06	1.22e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—AGT—coronary artery disease	1.18e-06	1.2e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALB—coronary artery disease	1.17e-06	1.19e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—APOE—coronary artery disease	1.15e-06	1.18e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—APOA1—coronary artery disease	1.14e-06	1.16e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NOS3—coronary artery disease	1.12e-06	1.14e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CA—coronary artery disease	1.04e-06	1.07e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTGS2—coronary artery disease	1.02e-06	1.04e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PPARG—coronary artery disease	1e-06	1.02e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—POMC—coronary artery disease	9.89e-07	1.01e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CA—coronary artery disease	9.04e-07	9.23e-06	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALB—coronary artery disease	9.02e-07	9.2e-06	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NOS3—coronary artery disease	8.63e-07	8.8e-06	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—AKT1—coronary artery disease	8.53e-07	8.71e-06	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CA—coronary artery disease	8.07e-07	8.24e-06	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTGS2—coronary artery disease	7.89e-07	8.05e-06	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CA—coronary artery disease	7.88e-07	8.04e-06	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—AKT1—coronary artery disease	7.39e-07	7.54e-06	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CA—coronary artery disease	7.36e-07	7.51e-06	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—AKT1—coronary artery disease	6.59e-07	6.73e-06	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—AKT1—coronary artery disease	6.44e-07	6.57e-06	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CA—coronary artery disease	6.29e-07	6.42e-06	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—AKT1—coronary artery disease	6.01e-07	6.14e-06	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—AKT1—coronary artery disease	5.14e-07	5.24e-06	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CA—coronary artery disease	4.85e-07	4.95e-06	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—AKT1—coronary artery disease	3.97e-07	4.05e-06	CbGpPWpGaD
